協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/08/19 | 1,848 | 1,849 | 1,813 | 1,817 | +1 | +0.1% | 749,400 |
| 2019/08/16 | 1,803 | 1,832 | 1,802 | 1,816 | +16 | +0.9% | 1,715,500 |
| 2019/08/15 | 1,758 | 1,807 | 1,746 | 1,800 | +11 | +0.6% | 1,237,300 |
| 2019/08/14 | 1,818 | 1,827 | 1,776 | 1,789 | -4 | -0.2% | 1,128,000 |
| 2019/08/13 | 1,855 | 1,855 | 1,789 | 1,793 | -32 | -1.8% | 1,196,600 |
| 2019/08/09 | 1,836 | 1,851 | 1,823 | 1,825 | +29 | +1.6% | 1,728,400 |
| 2019/08/08 | 1,796 | 1,815 | 1,786 | 1,796 | +17 | +1% | 1,040,700 |
| 2019/08/07 | 1,734 | 1,788 | 1,733 | 1,779 | +47 | +2.7% | 1,476,200 |
| 2019/08/06 | 1,678 | 1,736 | 1,674 | 1,732 | +3 | +0.2% | 1,036,500 |
| 2019/08/05 | 1,752 | 1,753 | 1,692 | 1,729 | -48 | -2.7% | 2,376,800 |
| 2019/08/02 | 1,819 | 1,849 | 1,770 | 1,777 | -55 | -3% | 2,420,800 |
| 2019/08/01 | 1,786 | 1,836 | 1,772 | 1,832 | +29 | +1.6% | 1,436,300 |
| 2019/07/31 | 1,790 | 1,814 | 1,784 | 1,803 | -7 | -0.4% | 1,387,400 |
| 2019/07/30 | 1,811 | 1,819 | 1,802 | 1,810 | +34 | +1.9% | 3,251,000 |
| 2019/07/29 | 1,792 | 1,798 | 1,760 | 1,776 | -2 | -0.1% | 1,669,500 |
| 2019/07/26 | 1,765 | 1,783 | 1,759 | 1,778 | +4 | +0.2% | 1,037,700 |
| 2019/07/25 | 1,803 | 1,813 | 1,773 | 1,774 | -37 | -2% | 1,270,400 |
| 2019/07/24 | 1,813 | 1,818 | 1,805 | 1,811 | -10 | -0.5% | 1,124,600 |
| 2019/07/23 | 1,811 | 1,831 | 1,802 | 1,821 | +2 | +0.1% | 832,600 |
| 2019/07/22 | 1,822 | 1,844 | 1,813 | 1,819 | -21 | -1.1% | 994,900 |
| 2019/07/19 | 1,824 | 1,845 | 1,818 | 1,840 | +19 | +1% | 1,118,600 |
| 2019/07/18 | 1,870 | 1,875 | 1,816 | 1,821 | -54 | -2.9% | 1,041,500 |
| 2019/07/17 | 1,879 | 1,890 | 1,867 | 1,875 | -10 | -0.5% | 914,100 |
| 2019/07/16 | 1,901 | 1,911 | 1,885 | 1,885 | -29 | -1.5% | 718,900 |
| 2019/07/12 | 1,921 | 1,927 | 1,903 | 1,914 | ±0 | ±0% | 782,100 |
| 2019/07/11 | 1,920 | 1,924 | 1,908 | 1,914 | +1 | +0.1% | 699,400 |
| 2019/07/10 | 1,905 | 1,918 | 1,900 | 1,913 | +14 | +0.7% | 1,114,100 |
| 2019/07/09 | 1,915 | 1,924 | 1,890 | 1,899 | +3 | +0.2% | 1,226,100 |
| 2019/07/08 | 1,900 | 1,902 | 1,885 | 1,896 | -28 | -1.5% | 1,345,100 |
| 2019/07/05 | 1,921 | 1,930 | 1,908 | 1,924 | +8 | +0.4% | 1,350,500 |
| 2019/07/04 | 1,928 | 1,937 | 1,914 | 1,916 | -9 | -0.5% | 1,313,500 |
| 2019/07/03 | 1,921 | 1,943 | 1,915 | 1,925 | -27 | -1.4% | 1,227,900 |
| 2019/07/02 | 1,961 | 1,977 | 1,951 | 1,952 | -10 | -0.5% | 985,000 |
| 2019/07/01 | 1,943 | 1,969 | 1,937 | 1,962 | +23 | +1.2% | 1,309,700 |
| 2019/06/28 | 1,916 | 1,955 | 1,912 | 1,939 | +11 | +0.6% | 1,553,900 |
| 2019/06/27 | 1,949 | 1,949 | 1,916 | 1,928 | -29 | -1.5% | 1,343,000 |
| 2019/06/26 | 1,950 | 1,972 | 1,934 | 1,957 | -15 | -0.8% | 943,600 |
| 2019/06/25 | 1,975 | 2,005 | 1,970 | 1,972 | -9 | -0.5% | 931,000 |
| 2019/06/24 | 1,984 | 1,991 | 1,971 | 1,981 | -3 | -0.2% | 693,200 |
| 2019/06/21 | 2,029 | 2,034 | 1,981 | 1,984 | -47 | -2.3% | 1,187,500 |
| 2019/06/20 | 2,047 | 2,067 | 2,030 | 2,031 | +5 | +0.2% | 717,500 |
| 2019/06/19 | 2,029 | 2,039 | 2,018 | 2,026 | +11 | +0.5% | 744,500 |
| 2019/06/18 | 2,046 | 2,051 | 2,004 | 2,015 | -12 | -0.6% | 713,700 |
| 2019/06/17 | 2,033 | 2,052 | 2,023 | 2,027 | -7 | -0.3% | 695,900 |
| 2019/06/14 | 2,022 | 2,047 | 2,004 | 2,034 | +33 | +1.6% | 1,860,900 |
| 2019/06/13 | 2,020 | 2,020 | 1,982 | 2,001 | -20 | -1% | 966,300 |
| 2019/06/12 | 2,038 | 2,040 | 2,021 | 2,021 | -37 | -1.8% | 802,300 |
| 2019/06/11 | 2,022 | 2,064 | 2,020 | 2,058 | +38 | +1.9% | 787,200 |
| 2019/06/10 | 2,043 | 2,043 | 2,014 | 2,020 | +9 | +0.4% | 833,800 |
| 2019/06/07 | 2,015 | 2,029 | 2,011 | 2,011 | -11 | -0.5% | 523,700 |
1401～
1450
件表示中 / 3699件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,200円 | -3.5% | -11.3% | 2.76% | 19.95倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 134,100円 | +0.9% | +380.2% | 5.82% | 18.47倍 | 1.59倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 218,800円 | +20.9% | +10.6% | 3.02% | 10.34倍 | 1.37倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 366,700円 | +1.7% | -2.9% | 4.36% | 24.06倍 | 1.27倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 149,200円 | +0.6% | +43.3% | 5.36% | 10.46倍 | 0.89倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
